Shaomeng Wang Selected Research

Ovarian Neoplasms (Ovarian Cancer)

7/2012	AT-406, an orally active antagonist of multiple inhibitor of apoptosis proteins, inhibits progression of human ovarian cancer.
3/2012	LRIG1 modulates cancer cell sensitivity to Smac mimetics by regulating TNFα expression and receptor tyrosine kinase signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shaomeng Wang Research Topics

Disease

122	Neoplasms (Cancer) 03/2024 - 07/2003
28	Prostatic Neoplasms (Prostate Cancer) 03/2024 - 05/2004
22	Leukemia 01/2023 - 01/2005
22	Breast Neoplasms (Breast Cancer) 01/2023 - 11/2004
10	Lymphoma (Lymphomas) 01/2020 - 01/2005
7	Lung Neoplasms (Lung Cancer) 11/2022 - 06/2008
7	Squamous Cell Carcinoma of Head and Neck 01/2016 - 11/2004
5	B-Cell Lymphoma (Lymphoma, B Cell) 12/2022 - 01/2005
5	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2021 - 02/2008
5	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2020 - 05/2012
4	Head and Neck Neoplasms (Head and Neck Cancer) 01/2016 - 07/2005
4	Pancreatic Neoplasms (Pancreatic Cancer) 04/2010 - 11/2005
4	Parkinson Disease (Parkinson's Disease) 07/2006 - 02/2003
3	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2021
3	Carcinogenesis 12/2021 - 11/2013
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 07/2008
3	Hypothermia 12/2019 - 08/2007
3	Colonic Neoplasms (Colon Cancer) 10/2014 - 06/2008
3	Carcinoma (Carcinomatosis) 11/2013 - 07/2003
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 09/2008 - 01/2005
3	Schizophrenia (Dementia Praecox) 07/2006 - 10/2003
3	Cocaine-Related Disorders (Cocaine Addiction) 07/2006 - 02/2003
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 01/2020
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2022 - 02/2008
2	COVID-19 01/2021 - 12/2020
2	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 03/2007
2	Esophageal Neoplasms (Esophageal Cancer) 01/2020 - 11/2013
2	Graft vs Host Disease (Graft-Versus-Host Disease) 08/2017 - 04/2015
2	Adenoid Cystic Carcinoma (Cylindroma) 02/2017 - 09/2015
2	Osteosarcoma (Osteogenic Sarcoma) 01/2015 - 10/2014
2	Ovarian Neoplasms (Ovarian Cancer) 07/2012 - 03/2012

Drug/Important Bio-Agent (IBA)

77	Proteins (Proteins, Gene)FDA Link 03/2024 - 10/2003
14	Androgen Receptors (Androgen Receptor)IBA 03/2024 - 01/2018
14	snake venom protein C activatorIBA 03/2024 - 08/2018
13	GossypolIBA 08/2010 - 07/2003
11	Inhibitor of Apoptosis ProteinsIBA 04/2016 - 02/2005
9	CaspasesIBA 12/2022 - 09/2004
7	Proteolysis Targeting ChimeraIBA 03/2024 - 08/2018
6	enzalutamideIBA 03/2024 - 01/2016
6	Estrogen ReceptorsIBA 01/2023 - 12/2016
6	MethyltransferasesIBA 01/2023 - 07/2010
6	Phosphotransferases (Kinase)IBA 12/2020 - 02/2006
6	LigandsIBA 04/2020 - 10/2003
6	Cisplatin (Platino)FDA LinkGeneric 02/2017 - 08/2004
6	SM 164IBA 05/2012 - 12/2007
5	AndrogensIBA 01/2023 - 01/2007
5	N- benzhydryl- 5- (2- (methylamino)propanamido)- 3- (3- methylbutanoyl)- 6- oxodecahydropyrrolo(1,2- a)(1,5)diazocine- 8- carboxamideIBA 08/2017 - 04/2011
5	Caspase 9IBA 05/2012 - 05/2004
4	Histones (Histone)IBA 03/2024 - 07/2010
4	Lysine (L-Lysine)FDA Link 03/2024 - 07/2010
4	ErbB Receptors (EGF Receptor)IBA 07/2022 - 07/2006
4	PeptidomimeticsIBA 12/2017 - 02/2013
4	SAR405838IBA 12/2016 - 10/2014
4	MI-219IBA 01/2016 - 03/2008
4	Oncogene Proteins (Oncogene Protein)IBA 01/2015 - 06/2008
4	Dopamine (Intropin)FDA LinkGeneric 08/2007 - 02/2003
3	ChromatinIBA 03/2024 - 10/2017
3	Transcription Factors (Transcription Factor)IBA 03/2024 - 10/2017
3	tyrosine receptor (receptor, tyrosine)IBA 11/2022 - 03/2012
3	Carboplatin (JM8)FDA LinkGeneric 07/2022 - 11/2008
3	Tyrosine Kinase InhibitorsIBA 07/2022 - 03/2012
3	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 06/2021 - 11/2019
3	MI-773IBA 01/2019 - 01/2016
3	Docetaxel (Taxotere)FDA Link 01/2016 - 02/2012
3	gossypol acetic acidIBA 01/2016 - 08/2010
3	X-Linked Inhibitor of Apoptosis ProteinIBA 04/2014 - 11/2006
3	Biomarkers (Surrogate Marker)IBA 11/2013 - 02/2008
3	Peptides (Polypeptides)IBA 05/2013 - 07/2010
3	Caspase 3 (Caspase-3)IBA 01/2012 - 09/2008
3	PolyphenolsIBA 11/2008 - 02/2005
3	NF-kappa B (NF-kB)IBA 10/2008 - 11/2005
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2023 - 01/2020
2	Leucine (L-Leucine)FDA Link 01/2023 - 01/2019
2	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 11/2022 - 11/2022
2	Paclitaxel (Taxol)FDA LinkGeneric 07/2022 - 11/2008
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 07/2022 - 12/2006
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 07/2022 - 01/2020
2	Cysteine (L-Cysteine)FDA Link 01/2021 - 05/2008
2	Anaplastic Lymphoma KinaseIBA 11/2020 - 03/2016
2	ARD-61IBA 10/2020 - 01/2020
2	Fulvestrant (Faslodex)FDA Link 04/2020 - 12/2016
2	abirateroneIBA 01/2019 - 01/2016
2	Amino Acids FDA Link 01/2019 - 11/2016
2	Adenosine Triphosphatases (ATPase)IBA 01/2019 - 08/2009
2	indoleIBA 01/2018 - 11/2017
2	MM-401IBA 01/2017 - 01/2014
2	compound 18IBA 01/2017 - 06/2015
2	CrizotinibIBA 03/2016 - 03/2012
2	Androgen Antagonists (Antiandrogens)IBA 01/2016 - 01/2016
2	nutlin 3IBA 01/2016 - 12/2009
2	Apoptosis Regulatory ProteinsIBA 11/2015 - 05/2013
2	BM-1197IBA 09/2015 - 01/2014
2	molibresibIBA 06/2014 - 10/2013
2	Messenger RNA (mRNA)IBA 11/2013 - 01/2004

Therapy/Procedure

51	Therapeutics 03/2024 - 03/2003
14	Castration 03/2024 - 08/2010
10	Oral Administration 03/2024 - 07/2013
9	Drug Therapy (Chemotherapy) 02/2017 - 11/2004
6	Radiotherapy 01/2016 - 10/2003
2	Immunotherapy 01/2021 - 01/2020